Gainers
- Kezar Life Sciences, Inc. (NASDAQ:KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).
- Sutro Biopharma, Inc. (NASDAQ:STRO) rose 34.4% to $5.82 in pre-market trading. Astellas and Sutro Biopharma disclosed a worldwide, strategic collaboration and licensing agreement to advance novel immunostimulatory antibody-drug conjugates.
- Agile Therapeutics, Inc. (NASDAQ:AGRX) rose 33% to $1.69 in pre-market trading. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
- Tuniu Corporation (NASDAQ:TOUR) rose 31.7% to $0.68 in pre-market trading. Tuniu recently posted Q1 sales of $6.54 million.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 23.4% to $1.32 in pre-market trading. Evofem Biosciences shares jumped around 188% on Monday amid the Supreme Court overturning Roe V Wade.
- InflaRx N.V. (NASDAQ:IFRX) rose 21.3% to $1.31 in pre-market trading after jumping 38% on Monday.
- Playtika Holding Corp. (NASDAQ:PLTK) rose 18.1% to $17.00 in pre-market trading. Morgan Stanley recently maintained Playtika Holding with an Overweight and lowered the price target from $23 to $21.
- Aspira Women's Health Inc. (NASDAQ:AWH) shares rose 17.6% to $0.8010 in pre-market trading. Aspira Women's Health shares jumped over 32% on Monday amid the Supreme Court overturning Roe V Wade.
- Ceragon Networks Ltd. (NASDAQ:CRNT) shares rose 17.2% to $2.45 in pre-market trading after Aviat Networks, Inc. proposed to acquire the company for $2.80 per share in cash.
- Trip.com Group Limited (NASDAQ:TCOM) rose 15.6% to $28.41 in pre-market trading after reporting a rise in Q1 sales.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 14.4% to $0.99 in pre-market trading.
- ThermoGenesis Holdings, Inc. (NASDAQ:THMO) rose 14.1% to $0.3220 in pre-market trading. ThermoGenesis, last month, posted a Q1 loss of $0.16 per share.
- View, Inc. (NASDAQ:VIEW) rose 13.3% to $1.71 in pre-market trading after dropping 20% on Monday View recently reported first-quarter FY22 revenue growth of 74% year-on-year to $17 million, beating the consensus of $15.1 million.
- ENDRA Life Sciences Inc. (NASDAQ:NDRA) rose 13.3% to $0.2550 in pre-market trading.
- Huazhu Group Limited (NASDAQ:HTHT) rose 11.7% to $39.96 in pre-market trading.
- RealNetworks, Inc. (NASDAQ:RNWK) rose 9.2% to $0.66 in pre-market trading after the company announced a pilot program with Vodafone Germany to launch Vodafone CallProtect to warn customers of potential fraudulent, scam or spam-type calls.
- Melco Resorts & Entertainment Limited (NASDAQ:MLCO) rose 8.9% to $6.39 in pre-market trading.
- Edgio, Inc. (NASDAQ:EGIO) rose 8.7% to $2.50 in pre-market trading. Cowen & Co. recently maintained Edgio with an Outperform and lowered the price target from $5.5 to $5.
Don’t forget to check out our premarket coverage here .
Losers
- FGI Industries Ltd. (NASDAQ:FGI) fell 10.2% to $2.20 in pre-market trading. The company, last month, posted downbeat quarterly results.
- Drive Shack Inc. (NYSE:DS) fell 9.3% to $1.36 in pre-market trading. Drive Shack recently announced grand opening of Puttery Washington D.C.
- Benitec Biopharma Inc. (NASDAQ:BNTC) fell 9.1% to $1.40 in pre-market trading after jumping 26% on Monday.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 8.1% to $2.71 in pre-market trading after gaining over 9% on Monday. ToughBuilt recently priced a $6 million offering.
- IT Tech Packaging, Inc. (NYSE:ITP) shares fell 7.4% to $0.1370 in pre-market trading. IT Tech Packaging reported a 1-for-10 reverse stock split, effective July 7.
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) fell 7.2% to $2.32 in pre-market trading. NeuroSense Therapeutics shares jumped around 49% on Monday after the company reported results from a stage III ALS Biomarker study evaluating PrimeC.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) fell 6.8% to $2.32 in pre-market trading. Blue Hat Interactive recently terminated its previously proposed shelf takedown offering.
